ACETAMINOPHEN

ACETAMINOPHEN was reported 453663 times

ACETAMINOPHEN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD PRESSURE DIASTOLIC ABNORMAL 1881 0.7388
1 BLOOD PRESSURE SYSTOLIC ABNORMAL 1727 0.6981
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 458 0.6856
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 4675 0.6518
4 LUPUS VULGARIS 821 0.6516
5 RHEUMATIC FEVER 2882 0.6459
6 DEEP VEIN THROMBOSIS POSTOPERATIVE 1283 0.6405
7 SWOLLEN JOINT COUNT INCREASED 2022 0.6335
8 DUODENAL ULCER PERFORATION 4671 0.6275
9 C-REACTIVE PROTEIN 579 0.6246
10 FACET JOINT SYNDROME 1808 0.5548
11 EXPOSURE TO TOXIC AGENT 1706 0.5328
12 RHEUMATOID FACTOR POSITIVE 2964 0.5126
13 MUSCLE INJURY 4065 0.4901
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1014 0.4889
15 HELICOBACTER INFECTION 4813 0.4678
16 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3010 0.4630
17 X-RAY ABNORMAL 812 0.4536
18 DISLOCATION OF VERTEBRA 1007 0.4411
19 FOLLICULITIS 4620 0.4401
20 PEMPHIGUS 5333 0.4261
21 HAND DEFORMITY 5545 0.4223
22 ANALGESIC DRUG LEVEL INCREASED 614 0.3823
23 AUTISM SPECTRUM DISORDER 2039 0.3700
24 RETINITIS 629 0.3638
25 PERIPHERAL VENOUS DISEASE 1447 0.3540
26 SYNOVITIS 6248 0.3462
27 C-REACTIVE PROTEIN ABNORMAL 2154 0.3355
28 PERICARDITIS 5470 0.3252
29 INFUSION SITE DISCHARGE 477 0.2718
30 GLOSSODYNIA 5557 0.2480
31 ACUTE HEPATIC FAILURE 3303 0.2415
32 PORPHYRIA ACUTE 341 0.2376
33 SEDATION COMPLICATION 601 0.2353
34 BURSITIS 2844 0.2342
35 BLOOD PRESSURE DIASTOLIC DECREASED 1719 0.2326
36 IRRITABLE BOWEL SYNDROME 4973 0.2317
37 BONE EROSION 800 0.2260
38 TEMPERATURE REGULATION DISORDER 501 0.2247
39 INFUSION SITE PRURITUS 686 0.2172
40 HYPERPARATHYROIDISM SECONDARY 544 0.2169
41 LIP DRY 1962 0.2158
42 BREAST CANCER STAGE III 1386 0.2138
43 INFUSION RELATED REACTION 14175 0.2136
44 NEPHROGENIC ANAEMIA 989 0.2133
45 BLOOD PRESSURE DIASTOLIC INCREASED 981 0.2123
46 WOUND 5852 0.2091
47 DRUG TOLERANCE DECREASED 584 0.2078
48 HYPERCHOLESTEROLAEMIA 1968 0.2036
49 INFUSION SITE BRUISING 437 0.2021
50 JOINT RANGE OF MOTION DECREASED 2713 0.2021
51 BLOOD PRESSURE SYSTOLIC INCREASED 3907 0.2001
52 GRIP STRENGTH DECREASED 1747 0.1983
53 ONYCHOMADESIS 821 0.1954
54 WOUND INFECTION 2088 0.1905
55 INFUSION SITE HAEMORRHAGE 624 0.1895
56 BLOOD PRESSURE FLUCTUATION 4543 0.1891
57 CONTRAINDICATED PRODUCT ADMINISTERED 5638 0.1860
58 WHITE BLOOD CELLS URINE POSITIVE 345 0.1832
59 ONYCHOMYCOSIS 798 0.1817
60 LIVER INJURY 4380 0.1783
61 INFUSION SITE SWELLING 1114 0.1769
62 POISONING DELIBERATE 1623 0.1710
63 SYSTEMIC LUPUS ERYTHEMATOSUS 6073 0.1709
64 EAR PRURITUS 599 0.1707
65 LIVE BIRTH 1392 0.1662
66 IMPAIRED HEALING 5352 0.1628
67 HEPATIC CYTOLYSIS 2068 0.1620
68 FIBROMYALGIA 3937 0.1618
69 FINGER DEFORMITY 768 0.1584
70 INFUSION SITE REACTION 472 0.1579
71 BLEPHAROSPASM 980 0.1555
72 AUTOIMMUNE DISORDER 1515 0.1553
73 MATERNAL EXPOSURE TIMING UNSPECIFIED 570 0.1516
74 CREATININE RENAL CLEARANCE DECREASED 602 0.1503
75 SUSPECTED SUICIDE 701 0.1494
76 INFUSION SITE ERYTHEMA 1256 0.1488
77 LOWER RESPIRATORY TRACT INFECTION 6701 0.1472
78 RADICULOPATHY 388 0.1471
79 INFUSION SITE PAIN 1857 0.1440
80 BODY TEMPERATURE DECREASED 1386 0.1407
81 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1556 0.1405
82 HEPATIC NECROSIS 525 0.1392
83 SCIATICA 2217 0.1389
84 PHYSICAL DECONDITIONING 353 0.1370
85 CHRONIC SINUSITIS 505 0.1344
86 REBOUND ACID HYPERSECRETION 405 0.1338
87 ARTHROPATHY 7242 0.1302
88 ATTENTION DEFICIT HYPERACTIVITY DISORDER 543 0.1288
89 END STAGE RENAL DISEASE 2325 0.1273
90 POOR VENOUS ACCESS 1312 0.1267
91 WALKING AID USER 832 0.1261
92 NAIL DISORDER 1099 0.1255
93 RED CELL DISTRIBUTION WIDTH INCREASED 518 0.1245
94 HEPATIC ENZYME INCREASED 8440 0.1237
95 INFUSION SITE EXTRAVASATION 744 0.1194
96 EXOSTOSIS 1081 0.1183
97 OBESITY 1884 0.1181
98 TYPE 2 DIABETES MELLITUS 3981 0.1181
99 THERAPEUTIC PRODUCT EFFECT DECREASED 5220 0.1164
100 BRONCHIECTASIS 779 0.1155
101 INCORRECT DRUG ADMINISTRATION RATE 485 0.1138
102 INTENTIONAL OVERDOSE 7231 0.1126
103 FOOD ALLERGY 867 0.1122
104 MULTIPLE DRUG OVERDOSE 556 0.1119
105 BLISTER 6277 0.1117
106 COELIAC DISEASE 1095 0.1115
107 HEART RATE DECREASED 3849 0.1095
108 SINUSITIS 11035 0.1076
109 BODY TEMPERATURE INCREASED 2186 0.1070
110 URINE ABNORMALITY 482 0.1059
111 PULMONARY FIBROSIS 2026 0.1055
112 INTENTIONAL PRODUCT USE ISSUE 9249 0.1055
113 IRON DEFICIENCY 473 0.1051
114 MULTIPLE ALLERGIES 824 0.1050
115 TOXICITY TO VARIOUS AGENTS 17603 0.1043
116 RESPIRATORY RATE INCREASED 923 0.1039
117 OSTEOARTHRITIS 4393 0.1035
118 STOMATITIS 6269 0.1033
119 COMPLETED SUICIDE 8609 0.1032
120 RHEUMATOID ARTHRITIS 11652 0.1025
121 EXPOSURE DURING PREGNANCY 6355 0.1021
122 METABOLIC ACIDOSIS 3246 0.1014
123 MONOCYTE COUNT INCREASED 368 0.1012
124 EAR PAIN 1965 0.1010
125 PRESCRIBED OVERDOSE 1945 0.1004
126 NIGHT SWEATS 3210 0.0995
127 SEASONAL ALLERGY 1409 0.0994
128 JOINT SWELLING 11980 0.0991
129 C-REACTIVE PROTEIN INCREASED 3600 0.0988
130 OXYGEN SATURATION DECREASED 5526 0.0982
131 SUSPECTED OFF LABEL USE 444 0.0982
132 DISCOMFORT 5996 0.0982
133 RALES 567 0.0975
134 BLOOD CALCIUM DECREASED 1090 0.0968
135 BACK INJURY 1051 0.0965
136 MUSCLE SPASTICITY 1184 0.0963
137 BLOOD CHOLESTEROL INCREASED 4492 0.0963
138 ATELECTASIS 928 0.0959
139 PSORIATIC ARTHROPATHY 3893 0.0958
140 SWELLING 8927 0.0953
141 LOWER LIMB FRACTURE 1824 0.0948
142 HIP ARTHROPLASTY 1452 0.0947
143 DRUG INTOLERANCE 9137 0.0945
144 JOINT DISLOCATION 995 0.0940
145 SPONDYLITIS 342 0.0940
146 ULCER HAEMORRHAGE 635 0.0937
147 CHRONIC KIDNEY DISEASE 7017 0.0923
148 FOOT DEFORMITY 1012 0.0912
149 GAIT INABILITY 3045 0.0910
150 WEIGHT FLUCTUATION 943 0.0900
151 HEPATITIS ACUTE 581 0.0893
152 COAGULOPATHY 1487 0.0892
153 DRUG-INDUCED LIVER INJURY 2782 0.0886
154 DRUG TOXICITY 1199 0.0879
155 URINARY TRACT DISORDER 396 0.0878
156 BREATH SOUNDS ABNORMAL 433 0.0877
157 HEPATOTOXICITY 1937 0.0869
158 VASCULAR DEVICE INFECTION 394 0.0868
159 EAR INFECTION 2307 0.0866
160 MACULAR DEGENERATION 1034 0.0865
161 PRODUCT LABEL CONFUSION 502 0.0860
162 CYTOKINE RELEASE SYNDROME 1726 0.0860
163 MOBILITY DECREASED 6175 0.0859
164 SPUTUM DISCOLOURED 799 0.0842
165 ILL-DEFINED DISORDER 5075 0.0835
166 BLOOD PRESSURE SYSTOLIC DECREASED 379 0.0832
167 PROTHROMBIN TIME PROLONGED 498 0.0832
168 MUSCULOSKELETAL STIFFNESS 7278 0.0830
169 INFLAMMATION 4278 0.0828
170 CARDIAC MURMUR 717 0.0828
171 LIVER FUNCTION TEST INCREASED 1778 0.0827
172 IMMUNODEFICIENCY 1233 0.0826
173 WHEEZING 4864 0.0819
174 RASH VESICULAR 394 0.0814
175 UPPER RESPIRATORY TRACT INFECTION 3764 0.0814
176 LUPUS-LIKE SYNDROME 713 0.0785
177 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 397 0.0783
178 HEPATIC ENCEPHALOPATHY 726 0.0777
179 APLASTIC ANAEMIA 404 0.0773
180 CONGENITAL ANOMALY 595 0.0768
181 MAJOR DEPRESSION 558 0.0763
182 GASTROINTESTINAL DISORDER 6801 0.0758
183 TASTE DISORDER 1533 0.0755
184 LYMPHOCYTE COUNT DECREASED 1335 0.0754
185 BLOOD URIC ACID INCREASED 436 0.0754
186 KNEE ARTHROPLASTY 1587 0.0753
187 ORTHOSTATIC HYPOTENSION 1301 0.0746
188 RHINITIS 602 0.0746
189 CONTUSION 7185 0.0746
190 HYPOPHOSPHATAEMIA 551 0.0745
191 SKIN LACERATION 810 0.0744
192 HEPATIC FAILURE 2243 0.0743
193 PERIPHERAL SWELLING 11457 0.0743
194 FOETAL DEATH 385 0.0742
195 HAEMOGLOBIN INCREASED 338 0.0740
196 DRUG LEVEL BELOW THERAPEUTIC 407 0.0737
197 SINUS CONGESTION 996 0.0736
198 JOINT EFFUSION 507 0.0735
199 SUICIDE ATTEMPT 4445 0.0732
200 TOXIC EPIDERMAL NECROLYSIS 1110 0.0730
201 SCOLIOSIS 451 0.0727
202 MUSCULOSKELETAL PAIN 3780 0.0721
203 COVID-19 PNEUMONIA 851 0.0720
204 NASOPHARYNGITIS 13258 0.0719
205 THROAT IRRITATION 3222 0.0717
206 TENDERNESS 745 0.0714
207 DELIRIUM 2479 0.0714
208 SKIN ABRASION 337 0.0712
209 APHTHOUS ULCER 549 0.0707
210 RENAL TUBULAR NECROSIS 694 0.0707
211 FEBRILE NEUTROPENIA 4689 0.0706
212 ANAL FISSURE 379 0.0706
213 PROTEIN URINE PRESENT 350 0.0701
214 LIVER DISORDER 3097 0.0698
215 OEDEMA 3780 0.0696
216 SPINAL OSTEOARTHRITIS 610 0.0694
217 ACIDOSIS 528 0.0690
218 LUNG DISORDER 3378 0.0689
219 TROPONIN INCREASED 524 0.0688
220 SLEEP DISORDER 4857 0.0687
221 RESPIRATORY DEPRESSION 843 0.0687
222 BRAIN OEDEMA 866 0.0685
223 ORAL CANDIDIASIS 902 0.0684
224 BLOOD PRESSURE INCREASED 10467 0.0684
225 HYPERVOLAEMIA 337 0.0681
226 HAEMORRHAGIC STROKE 532 0.0681
227 HYPOXIA 2399 0.0681
228 NEUTROPHIL COUNT INCREASED 697 0.0680
229 ABDOMINAL TENDERNESS 338 0.0680
230 RESPIRATORY TRACT INFECTION 1766 0.0677
231 JOINT STIFFNESS 1749 0.0666
232 PRESCRIBED UNDERDOSE 1328 0.0665
233 INTERVERTEBRAL DISC DEGENERATION 615 0.0664
234 SEDATION 1738 0.0663
235 HAEMATOCRIT DECREASED 1315 0.0662
236 TUBULOINTERSTITIAL NEPHRITIS 1242 0.0662
237 ACUTE KIDNEY INJURY 10123 0.0661
238 HYPERTRANSAMINASAEMIA 460 0.0661
239 ABDOMINAL DISCOMFORT 11076 0.0660
240 GINGIVAL PAIN 524 0.0658
241 GENERAL PHYSICAL HEALTH DETERIORATION 7560 0.0653
242 FLANK PAIN 611 0.0651
243 HEPATITIS 1666 0.0650
244 CONFUSIONAL STATE 10516 0.0650
245 HEART RATE IRREGULAR 1470 0.0650
246 DEPRESSED LEVEL OF CONSCIOUSNESS 2572 0.0649
247 FAILURE TO THRIVE 337 0.0648
248 TOOTH INFECTION 854 0.0647
249 BREAST CANCER STAGE II 537 0.0645
250 INFECTION 9315 0.0643
251 NECK PAIN 3588 0.0641
252 SKIN INFECTION 719 0.0640
253 TOOTH ABSCESS 650 0.0638
254 INJURY 4481 0.0637
255 UPPER-AIRWAY COUGH SYNDROME 523 0.0634
256 PRODUCTIVE COUGH 3021 0.0632
257 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3039 0.0632
258 CYSTITIS 2014 0.0632
259 SINUS DISORDER 1240 0.0626
260 HEPATIC CIRRHOSIS 1176 0.0625
261 LEUKOCYTOSIS 1131 0.0624
262 MATERNAL EXPOSURE DURING PREGNANCY 5551 0.0622
263 MYOSITIS 558 0.0621
264 ASPIRATION 678 0.0618
265 RESPIRATORY DISORDER 1849 0.0617
266 NEURALGIA 1500 0.0616
267 INSURANCE ISSUE 941 0.0615
268 GASTROOESOPHAGEAL REFLUX DISEASE 4937 0.0613
269 ULCER 975 0.0612
270 OSTEOPOROSIS 2520 0.0612
271 DERMATITIS CONTACT 697 0.0611
272 PULMONARY MASS 910 0.0610
273 SENSORY LOSS 490 0.0608
274 MIGRAINE 5804 0.0607
275 OSTEOPENIA 917 0.0604
276 CLOSTRIDIUM DIFFICILE COLITIS 640 0.0603
277 MYASTHENIA GRAVIS 486 0.0601
278 HYPERSENSITIVITY 11135 0.0599
279 LIGAMENT SPRAIN 593 0.0599
280 BRONCHITIS 4437 0.0599
281 PYREXIA 20713 0.0598
282 ARTHRITIS 4699 0.0597
283 HYPERTENSION 12647 0.0596
284 APPENDICITIS 557 0.0596
285 DRY MOUTH 4835 0.0595
286 TREATMENT FAILURE 4927 0.0594
287 GENERALISED OEDEMA 736 0.0594
288 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1019 0.0594
289 ENCEPHALOPATHY 1454 0.0591
290 INTERNATIONAL NORMALISED RATIO INCREASED 1686 0.0591
291 BLOOD TEST ABNORMAL 829 0.0589
292 VASCULITIS 686 0.0588
293 HEAD DISCOMFORT 1039 0.0586
294 HEPATITIS CHOLESTATIC 353 0.0585
295 ROAD TRAFFIC ACCIDENT 2451 0.0585
296 RENAL CYST 464 0.0584
297 TRANSAMINASES INCREASED 1294 0.0581
298 NERVE COMPRESSION 537 0.0581
299 TRICUSPID VALVE INCOMPETENCE 462 0.0581
300 FREQUENT BOWEL MOVEMENTS 1569 0.0580
301 BLOOD MAGNESIUM DECREASED 501 0.0580
302 BLOOD ALBUMIN DECREASED 460 0.0579
303 ALANINE AMINOTRANSFERASE INCREASED 3560 0.0579
304 POSTOPERATIVE WOUND INFECTION 391 0.0578
305 ACUTE RESPIRATORY FAILURE 1111 0.0577
306 MUSCULOSKELETAL CHEST PAIN 892 0.0576
307 POISONING 724 0.0576
308 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4088 0.0574
309 SARS-COV-2 TEST POSITIVE 758 0.0573
310 PHARYNGITIS STREPTOCOCCAL 620 0.0572
311 DRUG LEVEL INCREASED 948 0.0572
312 HEART RATE INCREASED 5652 0.0570
313 LOCALISED INFECTION 1379 0.0570
314 BACTERAEMIA 674 0.0567
315 CONCUSSION 439 0.0566
316 DYSPEPSIA 5575 0.0566
317 RIB FRACTURE 1164 0.0565
318 SINUS TACHYCARDIA 803 0.0565
319 GANGRENE 340 0.0564
320 HYPOTHERMIA 570 0.0562
321 ARTHRALGIA 23403 0.0562
322 CHOLESTASIS 1079 0.0561
323 SEROTONIN SYNDROME 1079 0.0561
324 VITAMIN D DEFICIENCY 547 0.0560
325 LYMPHOEDEMA 387 0.0559
326 SLEEP APNOEA SYNDROME 1068 0.0559
327 RESPIRATORY TRACT CONGESTION 886 0.0557
328 BLOOD IRON DECREASED 661 0.0556
329 TACHYCARDIA 4928 0.0554
330 DRUG USE DISORDER 466 0.0554
331 ARTERIOSCLEROSIS CORONARY ARTERY 366 0.0552
332 THERAPY NON-RESPONDER 2483 0.0552
333 WEIGHT INCREASED 12368 0.0552
334 POST-TRAUMATIC STRESS DISORDER 370 0.0551
335 CARDIOMEGALY 677 0.0550
336 RECTAL HAEMORRHAGE 2361 0.0549
337 ASPARTATE AMINOTRANSFERASE INCREASED 2900 0.0545
338 CHILLS 6396 0.0545
339 COORDINATION ABNORMAL 761 0.0545
340 CARDIO-RESPIRATORY ARREST 2278 0.0544
341 OROPHARYNGEAL PAIN 5039 0.0544
342 PHARYNGITIS 675 0.0544
343 GASTROENTERITIS VIRAL 981 0.0543
344 RED BLOOD CELL COUNT DECREASED 1550 0.0542
345 PARAESTHESIA ORAL 782 0.0542
346 PRODUCT PACKAGING ISSUE 515 0.0541
347 ACCIDENTAL OVERDOSE 1981 0.0541
348 HEPATIC STEATOSIS 1005 0.0539
349 BLOOD ALKALINE PHOSPHATASE INCREASED 1334 0.0537
350 OCULAR DISCOMFORT 601 0.0535
351 HYPOTENSION 10738 0.0535
352 MEDICATION ERROR 2974 0.0535
353 SMALL INTESTINAL OBSTRUCTION 658 0.0534
354 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 415 0.0534
355 COMA 2543 0.0533
356 DECUBITUS ULCER 435 0.0533
357 PHOTOPHOBIA 1002 0.0532
358 HYPOAESTHESIA 7961 0.0531
359 EYE INFECTION 599 0.0530
360 NASAL CONGESTION 3116 0.0530
361 HIATUS HERNIA 686 0.0529
362 PRODUCT ADMINISTRATION INTERRUPTED 414 0.0527
363 BACTERIAL INFECTION 984 0.0527
364 PROCTALGIA 339 0.0527
365 GOUT 946 0.0527
366 ECCHYMOSIS 361 0.0526
367 IRON DEFICIENCY ANAEMIA 486 0.0526
368 OROPHARYNGEAL DISCOMFORT 475 0.0525
369 ABDOMINAL PAIN 12196 0.0524
370 BACK PAIN 12164 0.0523
371 PNEUMONIA 16947 0.0523
372 BLOOD URINE PRESENT 991 0.0521
373 CARDIOGENIC SHOCK 749 0.0521
374 JOINT INJURY 1115 0.0521
375 DYSPNOEA EXERTIONAL 1963 0.0521
376 HYPOALBUMINAEMIA 405 0.0520
377 KIDNEY INFECTION 1020 0.0519
378 HOSPICE CARE 513 0.0519
379 TOOTHACHE 940 0.0519
380 UROSEPSIS 479 0.0519
381 RHINORRHOEA 3349 0.0518
382 URINARY TRACT INFECTION 8832 0.0517
383 UPPER GASTROINTESTINAL HAEMORRHAGE 871 0.0517
384 RENAL INJURY 1535 0.0516
385 URTICARIA 8647 0.0516
386 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9302 0.0516
387 MALNUTRITION 577 0.0515
388 APPETITE DISORDER 341 0.0514
389 BLOOD UREA INCREASED 861 0.0514
390 NEPHROPATHY 479 0.0513
391 MENTAL STATUS CHANGES 1421 0.0511
392 HYPERAESTHESIA 420 0.0511
393 POOR QUALITY SLEEP 1100 0.0510
394 OVERDOSE 11019 0.0510
395 SPINAL DISORDER 483 0.0509
396 CYST 632 0.0509
397 PRODUCT LABEL ISSUE 345 0.0508
398 MUSCULAR WEAKNESS 5777 0.0508
399 OBSTRUCTIVE AIRWAYS DISORDER 565 0.0507
400 TACHYPNOEA 689 0.0506
401 PAIN IN JAW 1435 0.0506
402 ARTERIAL OCCLUSIVE DISEASE 398 0.0506
403 ABDOMINAL PAIN UPPER 10422 0.0506
404 CELLULITIS 2550 0.0506
405 HYPERBILIRUBINAEMIA 524 0.0505
406 BLOOD BILIRUBIN INCREASED 1366 0.0505
407 PRODUCT USE ISSUE 9489 0.0504
408 PRESYNCOPE 1225 0.0503
409 POST PROCEDURAL INFECTION 409 0.0502
410 RESPIRATORY SYNCYTIAL VIRUS INFECTION 437 0.0501
411 UNRESPONSIVE TO STIMULI 1292 0.0500
412 TOOTH DISORDER 1112 0.0500
413 VIRAL INFECTION 1660 0.0498
414 FLUID RETENTION 2534 0.0498
415 COUGH 13959 0.0497
416 DIVERTICULITIS 1378 0.0497
417 FULL BLOOD COUNT ABNORMAL 525 0.0496
418 PULMONARY CONGESTION 654 0.0496
419 NEUTROPENIC SEPSIS 354 0.0495
420 HYPERLIPIDAEMIA 592 0.0495
421 COVID-19 8686 0.0495
422 HYPOKALAEMIA 2279 0.0493
423 BLOOD CREATININE INCREASED 3221 0.0493
424 NEPHROLITHIASIS 2261 0.0492
425 DIVERTICULUM 350 0.0492
426 ANAL INCONTINENCE 443 0.0492
427 FOETAL EXPOSURE DURING PREGNANCY 4001 0.0492
428 PREGNANCY 983 0.0490
429 HEADACHE 30767 0.0490
430 FACIAL PAIN 438 0.0490
431 BLOOD CALCIUM INCREASED 430 0.0490
432 LIMB INJURY 1331 0.0490
433 PAIN 30038 0.0489
434 MITRAL VALVE INCOMPETENCE 553 0.0488
435 MOTOR DYSFUNCTION 497 0.0487
436 TOOTH FRACTURE 537 0.0487
437 CONSTIPATION 10618 0.0486
438 NODULE 635 0.0486
439 HYDRONEPHROSIS 364 0.0486
440 HAEMORRHOIDS 946 0.0484
441 ASCITES 1423 0.0484
442 HAEMOGLOBIN DECREASED 4966 0.0483
443 EOSINOPHIL COUNT INCREASED 403 0.0483
444 LOWER GASTROINTESTINAL HAEMORRHAGE 357 0.0482
445 INCREASED TENDENCY TO BRUISE 444 0.0482
446 RENAL FAILURE 6384 0.0480
447 ARTHROPOD BITE 356 0.0480
448 HEPATOMEGALY 472 0.0480
449 OEDEMA PERIPHERAL 5854 0.0480
450 SEPSIS 5353 0.0479
451 WHITE BLOOD CELL COUNT INCREASED 1841 0.0479
452 PRODUCT ADMINISTRATION ERROR 969 0.0479
453 PHARYNGEAL SWELLING 469 0.0479
454 DUODENAL ULCER 338 0.0479
455 VOMITING 22496 0.0478
456 CLOSTRIDIUM DIFFICILE INFECTION 1043 0.0477
457 PYELONEPHRITIS 414 0.0477
458 CHEST PAIN 8835 0.0477
459 PLEURAL EFFUSION 2901 0.0476
460 ALOPECIA 9361 0.0476
461 PAIN IN EXTREMITY 14044 0.0476
462 INFLUENZA 5303 0.0475
463 HAEMODYNAMIC INSTABILITY 362 0.0475
464 FATIGUE 36918 0.0474
465 SPINAL PAIN 555 0.0473
466 MUSCULOSKELETAL DISCOMFORT 814 0.0472
467 HAEMOLYSIS 365 0.0472
468 MUSCLE STRAIN 408 0.0471
469 HEMIPLEGIA 392 0.0471
470 HAEMATEMESIS 1193 0.0470
471 PELVIC FRACTURE 366 0.0470
472 COGNITIVE DISORDER 2189 0.0468
473 PAROSMIA 353 0.0467
474 CHOLELITHIASIS 1530 0.0466
475 WEIGHT DECREASED 12987 0.0465
476 FEELING COLD 1288 0.0462
477 ORAL PAIN 1032 0.0460
478 GASTROINTESTINAL INFECTION 413 0.0460
479 BLADDER DISORDER 457 0.0460
480 CONDITION AGGRAVATED 13978 0.0459
481 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1302 0.0459
482 COLITIS 1740 0.0459
483 LIVER FUNCTION TEST ABNORMAL 1334 0.0458
484 ATRIAL FLUTTER 366 0.0458
485 HYPERTHERMIA 350 0.0458
486 SUBSTANCE ABUSE 373 0.0458
487 CHEST DISCOMFORT 4692 0.0458
488 BACK DISORDER 745 0.0458
489 HYPONATRAEMIA 2580 0.0458
490 MOUTH ULCERATION 965 0.0458
491 DENTAL CARIES 506 0.0457
492 FOOT FRACTURE 867 0.0457
493 PNEUMONIA ASPIRATION 1142 0.0457
494 CANDIDA INFECTION 770 0.0456
495 INTENTIONAL PRODUCT MISUSE 3991 0.0455
496 ASTHMA 5147 0.0455
497 VITAMIN D DECREASED 389 0.0455
498 ADVERSE REACTION 603 0.0454
499 MICTURITION URGENCY 518 0.0453
500 PNEUMONIA BACTERIAL 416 0.0453
501 EAR DISCOMFORT 465 0.0453
502 FEELING HOT 2774 0.0452
503 SOMNOLENCE 9091 0.0451
504 ABSCESS 720 0.0451
505 BLOOD PRESSURE ABNORMAL 895 0.0450
506 DECREASED APPETITE 10453 0.0450
507 BODY HEIGHT DECREASED 481 0.0449
508 ESCHERICHIA INFECTION 370 0.0449
509 ASTHENIA 16910 0.0449
510 RASH MACULO-PAPULAR 1000 0.0449
511 BLOOD SODIUM DECREASED 847 0.0449
512 ANAPHYLACTIC REACTION 2479 0.0448
513 PULMONARY OEDEMA 2005 0.0447
514 GASTRIC ULCER 849 0.0446
515 ADRENAL INSUFFICIENCY 541 0.0445
516 FISTULA 501 0.0445
517 EATING DISORDER 948 0.0445
518 FALL 14806 0.0444
519 MIOSIS 357 0.0444
520 BLOOD POTASSIUM INCREASED 722 0.0444
521 HERPES ZOSTER 2553 0.0444
522 EMPHYSEMA 448 0.0444
523 EPILEPSY 1354 0.0442
524 BLOOD PRESSURE DECREASED 2935 0.0441
525 PLATELET COUNT INCREASED 575 0.0441
526 ASPHYXIA 360 0.0441
527 GASTROENTERITIS 643 0.0440
528 SKIN ULCER 1138 0.0440
529 BALANCE DISORDER 3798 0.0439
530 MASS 614 0.0439
531 SPINAL COMPRESSION FRACTURE 363 0.0439
532 STEVENS-JOHNSON SYNDROME 974 0.0438
533 TEMPERATURE INTOLERANCE 451 0.0437
534 URINE OUTPUT DECREASED 382 0.0437
535 PALLOR 1189 0.0436
536 SPLENOMEGALY 511 0.0436
537 THROAT TIGHTNESS 1174 0.0434
538 ROTATOR CUFF SYNDROME 556 0.0433
539 DYSPNOEA 24500 0.0432
540 WRIST FRACTURE 518 0.0432
541 RASH 18825 0.0431
542 INTERVERTEBRAL DISC PROTRUSION 943 0.0431
543 ALTERED STATE OF CONSCIOUSNESS 932 0.0430
544 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2242 0.0429
545 RESPIRATORY DISTRESS 1184 0.0429
546 ORAL HERPES 837 0.0428
547 HAEMATOCHEZIA 2366 0.0428
548 PRODUCT DISTRIBUTION ISSUE 397 0.0428
549 PERIPHERAL COLDNESS 587 0.0427
550 PSEUDOMONAS INFECTION 366 0.0426
551 VENTRICULAR FIBRILLATION 474 0.0426
552 SCHIZOPHRENIA 517 0.0425
553 ATRIAL SEPTAL DEFECT 356 0.0425
554 SNEEZING 953 0.0424
555 DIZZINESS POSTURAL 412 0.0424
556 LUNG INFILTRATION 375 0.0424
557 BLOOD POTASSIUM DECREASED 1275 0.0424
558 HAEMOPTYSIS 1178 0.0422
559 OESOPHAGITIS 460 0.0421
560 CATARACT 2507 0.0421
561 RESTLESS LEGS SYNDROME 765 0.0420
562 PURPURA 372 0.0420
563 RASH ERYTHEMATOUS 2007 0.0419
564 DRUG LEVEL DECREASED 427 0.0419
565 BRAIN FOG 657 0.0419
566 GLOMERULAR FILTRATION RATE DECREASED 515 0.0419
567 PRODUCT USE IN UNAPPROVED INDICATION 10364 0.0418
568 TRANSFUSION 438 0.0418
569 AMNESIA 2717 0.0417
570 HYPOMAGNESAEMIA 579 0.0415
571 ABDOMINAL DISTENSION 4334 0.0415
572 HYPERHIDROSIS 5337 0.0414
573 AFFECT LABILITY 398 0.0413
574 TINNITUS 1900 0.0413
575 PULMONARY HYPERTENSION 861 0.0413
576 ARTERIOSCLEROSIS 389 0.0413
577 HEMIPARESIS 700 0.0413
578 HERNIA 799 0.0413
579 FACIAL PARALYSIS 352 0.0413
580 SINUS BRADYCARDIA 399 0.0412
581 IMMUNOSUPPRESSION 364 0.0412
582 DISABILITY 816 0.0412
583 INSOMNIA 10989 0.0412
584 GROIN PAIN 361 0.0411
585 GAMMA-GLUTAMYLTRANSFERASE INCREASED 910 0.0410
586 INTENTIONAL SELF-INJURY 829 0.0410
587 GAIT DISTURBANCE 7830 0.0409
588 DRY THROAT 415 0.0408
589 SKIN LESION 1119 0.0408
590 OSTEOMYELITIS 737 0.0407
591 RENAL PAIN 431 0.0406
592 OFF LABEL USE 35598 0.0406
593 ATRIAL FIBRILLATION 3958 0.0406
594 PETECHIAE 424 0.0406
595 ELECTROLYTE IMBALANCE 472 0.0406
596 DECREASED ACTIVITY 438 0.0406
597 NAUSEA 32122 0.0405
598 LIMB DISCOMFORT 1255 0.0405
599 DEHYDRATION 5403 0.0405
600 CARPAL TUNNEL SYNDROME 567 0.0404
601 IMPAIRED QUALITY OF LIFE 582 0.0404
602 ECONOMIC PROBLEM 613 0.0404
603 ACUTE RESPIRATORY DISTRESS SYNDROME 714 0.0403
604 BLOOD LACTATE DEHYDROGENASE INCREASED 638 0.0402
605 THERAPEUTIC RESPONSE UNEXPECTED 1804 0.0402
606 INCONTINENCE 425 0.0402
607 SWOLLEN TONGUE 1255 0.0401
608 DIPLOPIA 1042 0.0401
609 PRURITUS 15416 0.0401
610 PNEUMONITIS 1092 0.0401
611 GASTRITIS 1053 0.0400
612 HYPERCALCAEMIA 494 0.0400
613 VAGINAL DISCHARGE 404 0.0399
614 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 678 0.0399
615 APHONIA 557 0.0399
616 BRADYCARDIA 2112 0.0398
617 DRUG ADMINISTRATION ERROR 1222 0.0398
618 ANAEMIA 7590 0.0398
619 TUMOUR LYSIS SYNDROME 350 0.0397
620 NIGHTMARE 1376 0.0397
621 HAEMATURIA 1361 0.0397
622 RESPIRATORY ARREST 1095 0.0397
623 FAECES DISCOLOURED 861 0.0397
624 THERAPEUTIC RESPONSE SHORTENED 1315 0.0396
625 DYSURIA 1458 0.0396
626 SECRETION DISCHARGE 496 0.0396
627 ILLNESS 4071 0.0395
628 CHOLECYSTITIS 470 0.0394
629 DIARRHOEA 25438 0.0394
630 ANGIOEDEMA 1740 0.0393
631 IMPAIRED GASTRIC EMPTYING 536 0.0393
632 SUPRAVENTRICULAR TACHYCARDIA 375 0.0391
633 EPISTAXIS 2921 0.0390
634 THROMBOCYTOPENIA 4366 0.0390
635 HYPERSOMNIA 1119 0.0390
636 LETHARGY 2243 0.0389
637 PARAESTHESIA 6128 0.0389
638 URINARY INCONTINENCE 1152 0.0388
639 NEUTROPHIL COUNT DECREASED 1584 0.0388
640 MUSCLE RIGIDITY 464 0.0388
641 SUBARACHNOID HAEMORRHAGE 395 0.0387
642 MYOCARDITIS 444 0.0387
643 HEPATOCELLULAR INJURY 548 0.0386
644 JAUNDICE 1040 0.0386
645 MUSCLE SPASMS 7074 0.0385
646 EOSINOPHILIA 675 0.0385
647 HALLUCINATION, VISUAL 811 0.0384
648 LYMPHADENOPATHY 1359 0.0384
649 GALLBLADDER DISORDER 685 0.0383
650 COLITIS ULCERATIVE 1714 0.0383
651 RESPIRATORY FAILURE 2792 0.0382
652 RETCHING 815 0.0382
653 MALAISE 16741 0.0381
654 INCORRECT DOSE ADMINISTERED 8707 0.0381
655 HYPOPHAGIA 974 0.0381
656 DYSPHAGIA 3613 0.0380
657 PLATELET COUNT DECREASED 4048 0.0379
658 PERICARDIAL EFFUSION 878 0.0379
659 SEPTIC SHOCK 1650 0.0379
660 HAEMATOMA 982 0.0379
661 BASAL CELL CARCINOMA 591 0.0378
662 STAPHYLOCOCCAL INFECTION 1249 0.0378
663 FULL BLOOD COUNT DECREASED 762 0.0378
664 CYANOSIS 594 0.0377
665 HEAD INJURY 1190 0.0376
666 DYSPHONIA 2195 0.0375
667 SHOCK 863 0.0375
668 PNEUMOTHORAX 593 0.0374
669 EYE PAIN 2108 0.0373
670 HYPOKINESIA 542 0.0373
671 BRONCHOSPASM 531 0.0372
672 NEUROPATHY PERIPHERAL 3530 0.0371
673 FUNGAL INFECTION 1235 0.0370
674 HYPERKALAEMIA 1296 0.0369
675 DIZZINESS 18408 0.0369
676 INFLUENZA LIKE ILLNESS 3036 0.0368
677 MEMORY IMPAIRMENT 5060 0.0368
678 PULMONARY THROMBOSIS 401 0.0367
679 DEVICE RELATED INFECTION 566 0.0367
680 HIP FRACTURE 1182 0.0367
681 DYSSTASIA 1073 0.0367
682 FLUSHING 3729 0.0366
683 WHITE BLOOD CELL COUNT DECREASED 3975 0.0366
684 PANCREATITIS ACUTE 824 0.0366
685 POST PROCEDURAL COMPLICATION 703 0.0366
686 BONE PAIN 2143 0.0365
687 DRUG INTERACTION 5803 0.0365
688 PULMONARY EMBOLISM 3470 0.0365
689 GINGIVAL BLEEDING 497 0.0364
690 ANXIETY 10341 0.0363
691 RENAL FAILURE ACUTE 1541 0.0363
692 TENDONITIS 558 0.0360
693 ERYTHEMA MULTIFORME 336 0.0360
694 FEEDING DISORDER 729 0.0359
695 LYMPHOPENIA 508 0.0359
696 ANKYLOSING SPONDYLITIS 473 0.0359
697 FACE OEDEMA 603 0.0357
698 DEPRESSION 8113 0.0356
699 HOT FLUSH 2687 0.0356
700 CONJUNCTIVITIS 661 0.0356
701 RASH PRURITIC 1928 0.0355
702 DYSARTHRIA 1339 0.0355
703 MYDRIASIS 454 0.0354
704 APHASIA 1065 0.0352
705 SYNCOPE 3528 0.0352
706 UVEITIS 478 0.0352
707 ANGINA PECTORIS 1007 0.0351
708 BONE DISORDER 640 0.0351
709 DEEP VEIN THROMBOSIS 2274 0.0350
710 HALLUCINATION 2634 0.0349
711 GLAUCOMA 673 0.0349
712 SPINAL FRACTURE 699 0.0349
713 PANCYTOPENIA 1948 0.0348
714 MUCOSAL INFLAMMATION 911 0.0348
715 URINARY RETENTION 1159 0.0347
716 VERTIGO 2115 0.0347
717 LABORATORY TEST ABNORMAL 1024 0.0347
718 ANKLE FRACTURE 536 0.0346
719 SKIN HAEMORRHAGE 513 0.0346
720 NOCTURIA 419 0.0345
721 PALPITATIONS 4037 0.0344
722 DECREASED IMMUNE RESPONSIVENESS 338 0.0344
723 SWELLING FACE 2242 0.0344
724 MUSCLE TIGHTNESS 557 0.0343
725 HYPOGLYCAEMIA 1665 0.0343
726 CARDIAC ARREST 2831 0.0343
727 BRAIN INJURY 342 0.0341
728 MYALGIA 5791 0.0340
729 SCAR 581 0.0339
730 INITIAL INSOMNIA 348 0.0339
731 AGRANULOCYTOSIS 630 0.0339
732 HYPOAESTHESIA ORAL 509 0.0337
733 SCAB 385 0.0337
734 DRUG ABUSE 2809 0.0337
735 MELAENA 738 0.0335
736 BEDRIDDEN 439 0.0334
737 MUSCLE TWITCHING 767 0.0332
738 PRODUCT USE COMPLAINT 523 0.0332
739 INTESTINAL OBSTRUCTION 1249 0.0331
740 THYROID DISORDER 510 0.0331
741 MOVEMENT DISORDER 1061 0.0330
742 PANCREATITIS 1740 0.0329
743 RESTLESSNESS 1204 0.0329
744 LEUKOPENIA 1645 0.0329
745 ILEUS 408 0.0328
746 UPPER LIMB FRACTURE 653 0.0327
747 ERYTHEMA 6710 0.0326
748 SCRATCH 344 0.0326
749 PROCEDURAL PAIN 902 0.0325
750 POLLAKIURIA 1353 0.0324
751 SUBDURAL HAEMATOMA 464 0.0324
752 EJECTION FRACTION DECREASED 503 0.0323
753 GASTROINTESTINAL HAEMORRHAGE 2698 0.0322
754 MIDDLE INSOMNIA 602 0.0322
755 PHOTOSENSITIVITY REACTION 532 0.0322
756 MYOCLONUS 384 0.0322
757 CHOKING 628 0.0322
758 GASTROINTESTINAL PAIN 354 0.0321
759 AGITATION 2350 0.0320
760 CHROMATURIA 722 0.0320
761 TREMOR 5298 0.0319
762 MULTI-ORGAN FAILURE 551 0.0318
763 LIP SWELLING 1061 0.0318
764 COLD SWEAT 561 0.0318
765 ACCIDENT 380 0.0318
766 HYPERGLYCAEMIA 1159 0.0318
767 EXPIRED PRODUCT ADMINISTERED 1053 0.0316
768 BLOOD COUNT ABNORMAL 479 0.0316
769 INTENTIONAL DRUG MISUSE 658 0.0314
770 IMPAIRED WORK ABILITY 672 0.0314
771 DRY EYE 1565 0.0313
772 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 802 0.0311
773 ADVERSE DRUG REACTION 2798 0.0311
774 EYE DISORDER 1023 0.0311
775 MUSCULOSKELETAL DISORDER 591 0.0310
776 SKIN DISORDER 1035 0.0310
777 MUSCLE ATROPHY 393 0.0310
778 SKIN DISCOLOURATION 1422 0.0309
779 ANHEDONIA 813 0.0309
780 CARDIOMYOPATHY 457 0.0309
781 DEPRESSED MOOD 1633 0.0309
782 INJECTION SITE EXTRAVASATION 381 0.0308
783 NEUTROPENIA 4196 0.0308
784 DISSEMINATED INTRAVASCULAR COAGULATION 433 0.0307
785 RENAL DISORDER 1430 0.0307
786 ADVERSE EVENT 2827 0.0306
787 FEELING JITTERY 584 0.0306
788 INTERNAL HAEMORRHAGE 350 0.0306
789 PROTEINURIA 582 0.0306
790 TRANSIENT ISCHAEMIC ATTACK 1032 0.0306
791 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2175 0.0305
792 DIABETES MELLITUS INADEQUATE CONTROL 541 0.0305
793 THROMBOSIS 2444 0.0303
794 NEUROLEPTIC MALIGNANT SYNDROME 360 0.0303
795 IMMUNE SYSTEM DISORDER 399 0.0302
796 THERAPY PARTIAL RESPONDER 472 0.0302
797 FLATULENCE 1715 0.0302
798 RHABDOMYOLYSIS 1261 0.0302
799 LACTIC ACIDOSIS 978 0.0302
800 HYPOTHYROIDISM 964 0.0302
801 DISORIENTATION 1196 0.0302
802 VENTRICULAR TACHYCARDIA 498 0.0301
803 LACRIMATION INCREASED 910 0.0301
804 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1651 0.0301
805 GASTRIC DISORDER 1032 0.0300
806 CORONARY ARTERY DISEASE 910 0.0300
807 RASH MACULAR 1049 0.0300
808 ABDOMINAL PAIN LOWER 757 0.0299
809 PSYCHOTIC DISORDER 884 0.0299
810 SKIN REACTION 420 0.0298
811 INTENTIONAL DOSE OMISSION 850 0.0298
812 LOSS OF CONSCIOUSNESS 3813 0.0297
813 ATAXIA 353 0.0297
814 INCORRECT PRODUCT ADMINISTRATION DURATION 641 0.0296
815 ELECTROCARDIOGRAM QT PROLONGED 1062 0.0295
816 HYPOCALCAEMIA 558 0.0295
817 DRUG ERUPTION 519 0.0293
818 THIRST 523 0.0292
819 DEMENTIA 816 0.0292
820 RENAL IMPAIRMENT 2451 0.0291
821 DRUG INEFFECTIVE 38213 0.0290
822 SENSORY DISTURBANCE 465 0.0289
823 QUALITY OF LIFE DECREASED 388 0.0289
824 DELUSION 448 0.0288
825 BURNING SENSATION 2022 0.0288
826 UNDERDOSE 2099 0.0287
827 DEVICE OCCLUSION 403 0.0286
828 FLUID OVERLOAD 416 0.0286
829 SPEECH DISORDER 1490 0.0284
830 ANAPHYLACTIC SHOCK 733 0.0284
831 TOOTH EXTRACTION 351 0.0282
832 DYSGEUSIA 2095 0.0282
833 EYE SWELLING 1045 0.0281
834 METASTASES TO BONE 461 0.0281
835 TENDON RUPTURE 342 0.0277
836 PULMONARY ARTERIAL HYPERTENSION 400 0.0276
837 HAIR COLOUR CHANGES 342 0.0275
838 LUNG INFECTION 426 0.0274
839 BLOOD CREATINE PHOSPHOKINASE INCREASED 784 0.0272
840 SEIZURE 3137 0.0271
841 ACUTE MYOCARDIAL INFARCTION 799 0.0271
842 RASH PAPULAR 607 0.0271
843 INTERSTITIAL LUNG DISEASE 1310 0.0270
844 ORAL DISCOMFORT 375 0.0270
845 VISUAL IMPAIRMENT 3331 0.0269
846 DIABETES MELLITUS 2048 0.0268
847 VISION BLURRED 3685 0.0268
848 PARANOIA 462 0.0268
849 FEELING ABNORMAL 6408 0.0267
850 SKIN FISSURES 519 0.0265
851 DRUG EFFECT INCOMPLETE 961 0.0264
852 DISEASE PROGRESSION 3073 0.0259
853 ARRHYTHMIA 1229 0.0259
854 THERAPEUTIC RESPONSE DECREASED 1572 0.0259
855 AGEUSIA 644 0.0258
856 CARDIAC FAILURE CONGESTIVE 2056 0.0256
857 DEAFNESS 669 0.0256
858 FEMUR FRACTURE 790 0.0255
859 SKIN CANCER 547 0.0254
860 PLASMA CELL MYELOMA 989 0.0253
861 DISEASE RECURRENCE 1204 0.0253
862 DISTURBANCE IN ATTENTION 1364 0.0253
863 PRODUCT DOSE OMISSION IN ERROR 716 0.0253
864 GENERALISED TONIC-CLONIC SEIZURE 417 0.0252
865 PSYCHOMOTOR HYPERACTIVITY 418 0.0252
866 HAEMORRHAGE INTRACRANIAL 376 0.0251
867 TOOTH LOSS 520 0.0251
868 CRYING 911 0.0250
869 HALLUCINATION, AUDITORY 397 0.0250
870 PANIC ATTACK 910 0.0249
871 PARALYSIS 355 0.0248
872 PRODUCT DOSE OMISSION ISSUE 7285 0.0247
873 NERVOUSNESS 1291 0.0247
874 BLINDNESS 1006 0.0247
875 DYSKINESIA 1001 0.0246
876 PREMATURE BABY 734 0.0244
877 ISCHAEMIC STROKE 433 0.0242
878 INCREASED APPETITE 459 0.0240
879 HAEMORRHAGE 2488 0.0238
880 BONE DENSITY DECREASED 736 0.0235
881 TREATMENT NONCOMPLIANCE 1283 0.0234
882 BLOOD TRIGLYCERIDES INCREASED 413 0.0234
883 ECZEMA 1223 0.0233
884 CEREBRAL HAEMORRHAGE 834 0.0233
885 CARDIAC FAILURE 1870 0.0233
886 MULTIPLE FRACTURES 379 0.0230
887 MENTAL DISORDER 1002 0.0230
888 HEPATIC FUNCTION ABNORMAL 856 0.0229
889 CARDIAC DISORDER 2142 0.0229
890 EXTRA DOSE ADMINISTERED 925 0.0228
891 EYE PRURITUS 762 0.0227
892 PRODUCT PRESCRIBING ERROR 539 0.0226
893 MENTAL IMPAIRMENT 548 0.0226
894 DRUG EFFECT LESS THAN EXPECTED 335 0.0226
895 HYPOACUSIS 971 0.0225
896 METASTASES TO LIVER 395 0.0225
897 FRACTURE 422 0.0223
898 THINKING ABNORMAL 415 0.0222
899 LYMPHOMA 344 0.0222
900 CIRCULATORY COLLAPSE 376 0.0221
901 MULTIPLE SCLEROSIS 1055 0.0220
902 ERUCTATION 423 0.0218
903 CYTOMEGALOVIRUS INFECTION 360 0.0216
904 PRODUCT AVAILABILITY ISSUE 492 0.0216
905 CEREBROVASCULAR ACCIDENT 3629 0.0214
906 PREMATURE DELIVERY 340 0.0213
907 OCULAR HYPERAEMIA 1010 0.0213
908 FEAR 571 0.0212
909 PSORIASIS 2749 0.0210
910 SUICIDAL IDEATION 1902 0.0208
911 NEOPLASM PROGRESSION 719 0.0207
912 NERVOUS SYSTEM DISORDER 644 0.0206
913 SKIN EXFOLIATION 1705 0.0202
914 UNEVALUABLE EVENT 1527 0.0202
915 INCORRECT DRUG ADMINISTRATION DURATION 567 0.0201
916 MALIGNANT NEOPLASM PROGRESSION 2050 0.0200
917 DERMATITIS 417 0.0199
918 ABNORMAL BEHAVIOUR 786 0.0198
919 PRURITUS GENERALISED 429 0.0198
920 SURGERY 1156 0.0197
921 PELVIC PAIN 358 0.0197
922 INJECTION SITE REACTION 1353 0.0196
923 AGGRESSION 984 0.0196
924 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 456 0.0195
925 IRRITABILITY 1171 0.0195
926 PAIN OF SKIN 520 0.0193
927 PRODUCT PHYSICAL ISSUE 386 0.0191
928 THERAPY INTERRUPTED 1364 0.0191
929 HOSPITALISATION 2926 0.0190
930 MULTIPLE SCLEROSIS RELAPSE 1299 0.0189
931 MOOD SWINGS 591 0.0185
932 DEATH 15966 0.0185
933 RASH GENERALISED 477 0.0184
934 MOOD ALTERED 501 0.0184
935 ANGER 621 0.0183
936 DRY SKIN 2413 0.0181
937 ACTIVITIES OF DAILY LIVING IMPAIRED 352 0.0178
938 EMOTIONAL DISTRESS 2146 0.0177
939 OSTEONECROSIS OF JAW 435 0.0176
940 BONE MARROW FAILURE 357 0.0175
941 ABASIA 431 0.0174
942 EYE IRRITATION 991 0.0172
943 MYOCARDIAL INFARCTION 2976 0.0170
944 PERITONITIS 353 0.0170
945 EMOTIONAL DISORDER 525 0.0170
946 PRODUCT PRESCRIBING ISSUE 370 0.0170
947 THERAPY CESSATION 868 0.0169
948 CONVULSION 951 0.0166
949 BLOOD GLUCOSE DECREASED 771 0.0160
950 CEREBRAL INFARCTION 385 0.0157
951 ABNORMAL DREAMS 435 0.0157
952 PRODUCT QUALITY ISSUE 2117 0.0156
953 NEEDLE ISSUE 453 0.0155
954 NEOPLASM MALIGNANT 1034 0.0155
955 LUNG NEOPLASM MALIGNANT 635 0.0154
956 ACNE 1167 0.0154
957 OSTEONECROSIS 493 0.0150
958 BLOOD GLUCOSE INCREASED 2809 0.0149
959 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3009 0.0148
960 DIABETIC KETOACIDOSIS 356 0.0148
961 CARDIOVASCULAR DISORDER 376 0.0148
962 WITHDRAWAL SYNDROME 612 0.0146
963 DRUG EXPOSURE DURING PREGNANCY 493 0.0145
964 GLYCOSYLATED HAEMOGLOBIN INCREASED 362 0.0143
965 ABORTION SPONTANEOUS 557 0.0139
966 VAGINAL HAEMORRHAGE 597 0.0137
967 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 402 0.0137
968 PRODUCT DOSE OMISSION 891 0.0136
969 INJECTION SITE BRUISING 1057 0.0132
970 INJECTION SITE PRURITUS 860 0.0128
971 INJECTION SITE RASH 386 0.0126
972 INJECTION SITE ERYTHEMA 1559 0.0126
973 VISUAL ACUITY REDUCED 416 0.0125
974 DRUG EFFECT DECREASED 671 0.0124
975 DEVICE DISLOCATION 539 0.0124
976 INJECTION SITE MASS 450 0.0122
977 INJECTION SITE SWELLING 912 0.0119
978 SKIN IRRITATION 526 0.0115
979 DEVICE ISSUE 949 0.0106
980 PRODUCT SUBSTITUTION ISSUE 604 0.0105
981 DRUG DEPENDENCE 1679 0.0104
982 INJECTION SITE PAIN 3166 0.0103
983 INJECTION SITE HAEMORRHAGE 765 0.0096
984 BREAST CANCER 831 0.0089
985 ACCIDENTAL EXPOSURE TO PRODUCT 907 0.0088
986 DRUG DOSE OMISSION 1442 0.0087
987 SKIN BURNING SENSATION 621 0.0087
988 DEVICE MALFUNCTION 563 0.0080
989 DRUG WITHDRAWAL SYNDROME 703 0.0080
990 DEVICE LEAKAGE 337 0.0078
991 NO ADVERSE EVENT 1386 0.0076
992 DERMATITIS ATOPIC 394 0.0075
993 PROSTATE CANCER 419 0.0052
994 PRODUCT STORAGE ERROR 424 0.0048